SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-009286
Filing Date
2008-04-10
Accepted
2008-04-10 13:15:10
Documents
1
Period of Report
2008-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 18027
  Complete submission text file 0001140361-08-009286.txt   19958
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 9620 MEDICAL CENTER DRIVE C/O REXAHN PHARMACEUTICALS, INC. ROCKVILLE MD 20850
Business Address 240-268-5300
Beever Charles (Reporting) CIK: 0001361687 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50590 | Film No.: 08749481